AmerisourceBergen, a leading pharmaceutical solutions organisation announced its intent to change its name to ‘Cencora’ to better reflect its bold vision and
purpose-driven approach to creating healthier futures.
Steven H. Collis, Chairman, President & Chief Executive Officer of AmerisourceBergen said: “Over time, we have established ourselves as a trusted industry partner
that prioritizes innovation, advocates for patient access and advances strategic partnerships across the global pharmaceutical supply chain. To further bolster our
position, we must continue to adapt and evolve within our dynamic industry as we pursue the goal of enhancing health outcomes. Building a unified brand is fundamental
to our identity as a global healthcare company. We believe our new name better reflects who we are today and our impact across pharmaceutical care.”
AmerisourceBergen intends to begin operating as Cencora in the second half of calendar year 2023. The change to Cencora is aligned with the organisation’s growth
strategy and continued emphasis on innovation. AmerisourceBergen has focused on supporting pharmaceutical advancement and access for patients, manufacturers, and
providers across the global healthcare supply chain.